Insider Selling: Itron, Inc. (NASDAQ:ITRI) SVP Sells 107 Shares of Stock

Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP Laurie Ann Pulatie-Hahn sold 107 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $114.95, for a total transaction of $12,299.65. Following the sale, the senior vice president now owns 22,297 shares of the company's stock, valued at approximately $2,563,040.15. This represents a 0.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Itron Trading Up 2.1%

Shares of Itron stock traded up $2.44 during mid-day trading on Friday, hitting $116.15. The stock had a trading volume of 649,684 shares, compared to its average volume of 577,070. The firm has a 50-day moving average of $106.85 and a two-hundred day moving average of $107.70. Itron, Inc. has a 12-month low of $90.11 and a 12-month high of $124.90. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. The firm has a market cap of $5.30 billion, a P/E ratio of 23.80, a price-to-earnings-growth ratio of 0.81 and a beta of 1.31.

Itron (NASDAQ:ITRI - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The scientific and technical instruments company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.30 by $0.22. The firm had revenue of $607.15 million for the quarter, compared to analyst estimates of $608.86 million. Itron had a net margin of 9.37% and a return on equity of 19.03%. The business's revenue for the quarter was up .6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.24 EPS. Sell-side analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have issued reports on ITRI. Guggenheim reissued a "buy" rating and issued a $133.00 price objective on shares of Itron in a research note on Thursday, April 17th. Piper Sandler lowered their target price on shares of Itron from $124.00 to $121.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Wall Street Zen raised shares of Itron from a "hold" rating to a "buy" rating in a report on Saturday, May 24th. Oppenheimer upped their price objective on shares of Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Finally, Canaccord Genuity Group upped their price objective on shares of Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $127.36.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Strs Ohio acquired a new stake in shares of Itron in the first quarter valued at about $430,000. Intech Investment Management LLC grew its holdings in shares of Itron by 17.7% during the first quarter. Intech Investment Management LLC now owns 48,699 shares of the scientific and technical instruments company's stock worth $5,102,000 after buying an additional 7,336 shares in the last quarter. Bayforest Capital Ltd grew its holdings in shares of Itron by 43.9% during the first quarter. Bayforest Capital Ltd now owns 3,980 shares of the scientific and technical instruments company's stock worth $417,000 after buying an additional 1,215 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Itron by 129.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock worth $76,713,000 after buying an additional 413,487 shares in the last quarter. Finally, Optimize Financial Inc grew its holdings in shares of Itron by 2.7% during the first quarter. Optimize Financial Inc now owns 17,570 shares of the scientific and technical instruments company's stock worth $1,841,000 after buying an additional 463 shares in the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.